Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,839 companies covered, latest filing Oct 23.

  • $79.2M bought by 61 insiders at 47 companies
  • $239M sold by 49 insiders outside a trading plan
  • $2.5B sold by 203 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past week, each insider's filings added up.

  1. CRBGCorebridge Financial
    Life Insurance Co Nippon10% owner
    1,430,631 shares at $34.37 Oct 15–21, 5 filings +1.1% to stake 2 superinvestors bought in Q2
    $49.2M
  2. DOLEDole PLC
    Pale Fire Capital SE10% owner, +4 joint filers
    648,356 shares at $13.19 Oct 20–22 +6.7% to stake
    $8.6M
  3. APLDApplied Digital
    Jason Gechen ZhangPresident
    300,000 shares at $18.86 Oct 16 +12% to stake 5 superinvestors bought in Q2
    $5.7M
  4. RENTRent the Runway
    STORY3 Capital Partners, LLCDirector, +3 joint filers
    632,922 shares at $3.55 Oct 21 +15% to stake
    $2.2M
  5. RENTRent the Runway
    CHS US Investments LLC10% owner, +4 joint filers
    458,245 shares at $3.55 Oct 21 +2% to stake
    $1.6M
  6. FBKFB Financial
    Orrin H Ingram IIDirector
    29,081 shares at $52.88 Oct 20 +31% to stake
    $1.5M
  7. TENXTenax Therapeutics
    ADAR1 Capital Management, LLC10% owner, +1 joint filer
    922,849 shares at $1.59 Oct 19–21 +14% to stake
    $1.5M
  8. APLDApplied Digital
    Wes CumminsCEO
    55,803 shares at $18.04 Oct 16 +1% to stake 5 superinvestors bought in Q2
    $1M
  9. RAPPRapport Therapeutics
    Steven M PaulDirector
    35,714 shares at $27.28 Oct 22 +86% to stake
    $974K
  10. SNESSenesTech
    Glenbrook Capital Management10% owner
    1,087,679 shares at $0.7200 Oct 15–22, 2 filings
    $781K

Biggest sales

Past week, each insider's filings added up. Planned sales are marked.

  1. IHTInnSuites Hospitality Trust
    James F WirthCEO
    43,111 shares at $46,654.38 Oct 20 0.5% of stake Planned sale (10b5-1)
    $2B
  2. SNOWSnowflake
    Frank SlootmanDirector
    300,000 shares at $316.43 Oct 19 94% of stake Planned sale (10b5-1)
    $94.9M
  3. TALOTalos Energy
    Empresarial De Capitales S.a. De C.v. Control10% owner
    4,893,590 shares at $17.55 Oct 15–19, 2 filings 17% of stake
    $85.9M
  4. TRVTravelers
    Alan D SchnitzerCEO
    88,900 shares at $396.77 Oct 21 23% of stake
    $35.3M
  5. PATHUiPath
    Daniel DinesCEO
    2,500,000 shares at $13.23 Oct 15–16 7.9% of stake Planned sale (10b5-1)
    $33.1M
  6. UTHRUnited Therapeutics
    Martine A RothblattCEO
    47,500 shares at $555.06 Oct 16–22, 5 filings 13% of stake Planned sale (10b5-1)
    $26.4M
  7. MUMicron Technology
    Scott J DeboerPres. & Chief Tech & Prod Offr
    28,545 shares at $900.00 Oct 16 16% of stake Planned sale (10b5-1)
    $25.7M
  8. ALMRAlamar Biosciences
    Qiming Corporate GP VI, Ltd.10% owner, +6 joint filers
    733,811 shares at $28.64 Oct 15–22, 3 filings 29% of stake
    $21M
  9. SNOWSnowflake
    Benoit DagevilleDirector
    50,000 shares at $321.74 Oct 21 2.1% of stake Planned sale (10b5-1)
    $16.1M
  10. LINDLindblad Expeditions
    Sven-Olof LindbladDirector
    403,674 shares at $35.31 Oct 16–22, 2 filings 3.8% of stake Planned sale (10b5-1)
    $14.3M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

  1. TSMTaiwan Semiconductor 19 insiders, $80K

    Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

    Latest buy Oct 7 19 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group 11 insiders, $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. FULH. B. Fuller 9 insiders, $1.1M

    R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

    Latest buy Oct 16 1 executive 1 superinvestor bought in Q2
  4. RAPPRapport Therapeutics 6 insiders, $1.7M

    Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more

    Latest buy Oct 23 1 executive
  5. ATCHAtlasClear 5 insiders, $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  6. RGCORGC Resources 5 insiders, $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  7. WVVIWillamette Valley Vineyards 5 insiders, $75K

    Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more

    Latest buy Oct 12 3 executives
  8. MPBMid Penn Bancorp 5 insiders, $25K

    Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  9. DXDynex Capital 4 insiders, $245K

    Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

    Latest buy Oct 20 4 executives
  10. ANIXAnixa Biosciences 4 insiders, $203K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Oct 22 2 executives

META insider trades

Every open-market buy and sale in META, one row per filing, newest first

META page
  1. Robert M Kimmitt Director
    METAMeta Platforms
    Planned sale
    $371K 580 shares at $639.18 10% of stake
    Traded Feb 17 Filed Feb 19
  2. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $512K 801 shares at $639.18
    Traded Feb 17 Filed Feb 18
  3. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $343K 517 shares at $663.19 5.4% of stake
    Traded Feb 9 Filed Feb 11
  4. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $369K 517 shares at $714.60 5.1% of stake
    Traded Feb 2 Filed Feb 4
  5. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $344K 517 shares at $665.00 4.9% of stake
    Traded Jan 26 Filed Jan 28
  6. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $315K 517 shares at $608.35 4.6% of stake
    Traded Jan 20 Filed Jan 22
  7. Robert M Kimmitt Director
    METAMeta Platforms
    Planned sale
    $359K 580 shares at $618.28 9.4% of stake
    Traded Jan 15 Filed Jan 20
  8. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $338K 517 shares at $653.00 4.4% of stake
    Traded Jan 12 Filed Jan 14
  9. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $336K 517 shares at $650.41 4.2% of stake
    Traded Jan 5 Filed Jan 7
  10. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $342K 519 shares at $658.69 1.8% of stake
    Traded Dec 30, 2025 Filed Dec 30, 2025
  11. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $340K 517 shares at $658.14 4.1% of stake
    Traded Dec 29, 2025 Filed Dec 30, 2025
  12. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $342K 517 shares at $661.11 3.9% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
  13. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $342K 519 shares at $659.38 1.7% of stake
    Traded Dec 23, 2025 Filed Dec 23, 2025
  14. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $334K 519 shares at $643.23 1.7% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
  15. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $334K 517 shares at $646.00 3.8% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
  16. Robert M Kimmitt Director
    METAMeta Platforms
    Planned sale
    $375K 580 shares at $646.00 8.6% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
  17. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $345K 519 shares at $664.16 1.7% of stake
    Traded Dec 9, 2025 Filed Dec 11, 2025
  18. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $346K 517 shares at $669.63 3.6% of stake
    Traded Dec 8, 2025 Filed Dec 10, 2025
  19. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $333K 519 shares at $642.22 1.7% of stake
    Traded Dec 2, 2025 Filed Dec 4, 2025
  20. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $330K 517 shares at $639.03 3.5% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
  21. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $309K 517 shares at $598.54 3.4% of stake
    Traded Nov 24, 2025 Filed Nov 26, 2025
  22. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $324K 519 shares at $624.14 1.6% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025
  23. Andrew Bosworth Chief Technology Officer
    METAMeta Platforms
    Planned sale
    $6.9M 11,690 shares at $593.31 83% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
  24. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $307K 519 shares at $591.60 1.5% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
  25. Aaron Anderson Chief Accounting Officer
    METAMeta Platforms
    Planned sale
    $430K 726 shares at $591.60 11% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
  26. Robert M Kimmitt Director
    METAMeta Platforms
    Planned sale
    $366K 600 shares at $609.35 7.6% of stake
    Traded Nov 17, 2025 Filed Nov 19, 2025
  27. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $312K 517 shares at $604.23 3.3% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
  28. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $326K 517 shares at $631.00 6.9% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  29. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $326K 516 shares at $631.00 1.9% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  30. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $326K 519 shares at $628.00 1.9% of stake
    Traded Nov 4, 2025 Filed Nov 6, 2025
  31. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $339K 517 shares at $656.00 6.5% of stake
    Traded Nov 3, 2025 Filed Nov 5, 2025
  32. Peggy Alford Director
    METAMeta Platforms
    Planned sale
    $405K 601 shares at $674.40 15% of stake
    Traded Oct 31, 2025 Filed Nov 4, 2025
  33. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $391K 519 shares at $753.00 1.8% of stake
    Traded Oct 28, 2025 Filed Oct 30, 2025
  34. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $388K 517 shares at $749.57 6.1% of stake
    Traded Oct 27, 2025 Filed Oct 29, 2025
  35. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $382K 519 shares at $736.37 1.8% of stake
    Traded Oct 21, 2025 Filed Oct 23, 2025
  36. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $373K 517 shares at $721.30 5.7% of stake
    Traded Oct 20, 2025 Filed Oct 22, 2025
  37. Robert M Kimmitt Director
    METAMeta Platforms
    Planned sale
    $333K 465 shares at $716.97 5.5% of stake
    Traded Oct 15, 2025 Filed Oct 17, 2025
  38. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $367K 519 shares at $707.85 1.8% of stake
    Traded Oct 14, 2025 Filed Oct 16, 2025
  39. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $369K 517 shares at $713.34 5.4% of stake
    Traded Oct 13, 2025 Filed Oct 15, 2025
  40. Jennifer Newstead Chief Legal Officer
    METAMeta Platforms
    Planned sale
    $372K 519 shares at $716.98 1.7% of stake
    Traded Oct 7, 2025 Filed Oct 9, 2025
  41. Javier Olivan COO
    METAMeta Platforms
    Planned sale
    $364K 517 shares at $704.81 5.2% of stake
    Traded Oct 6, 2025 Filed Oct 8, 2025

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,839 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.